IN8bio stockholders elect directors, approve 2023 equity plan and auditor at annual meeting

IN8BIO, INC.

Peter Brandt and Travis Whitfill elected as directors; votes for 16.1M and 12.6M, respectively.
Stockholders ratified Amended and Restated 2023 Equity Incentive Plan with 15.8M for, 717k against, 25.9k abstain.
CohnReznick LLP ratified as independent auditor for FY 2023: 18.96M for, 43.6k against, 36.8k abstain.
Annual meeting held June 15, 2023; all proposals approved as recommended by board.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

IN8BIO, INC. shareholders approved Ratification of the Amended and Restated 2023 Equity Incentive Plan (the "2023 Plan"). at the 2023-06-15 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Proposal No. 2 : Ratification of the Amended and Restated 2023 Equity Incentive Plan (the " 2023 Plan ").

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

IN8BIO, INC. shareholders approved Ratification of the appointment of CohnReznick LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Proposal No. 3 : Ratification of the appointment of CohnReznick LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

IN8BIO, INC. shareholders approved Election of two nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. at the 2023-06-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Proposal No. 1 : Election of two nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified.

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

IN8BIO, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-169011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.